Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Leonard T. Heffner et al.|The Lancet Oncology|2014Cited by 1.3k
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaCarmen Scheibenbogen, Ulrich Keilholz, Anne Letsch et al.|Blood|2002Cited by 251
Natural T cell immunity against cancer.Dirk Nagorsen, Ulrich Keilholz, Carmen Scheibenbogen et al.|PubMed|2003Cited by 196
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumorsAlbiruni RA Razak, Kyriakos P. Papadopoulos, James M. Cleary et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 117